At 4 months old, Raegen was diagnosed with congenital nephrotic syndrome.Early on in Raegen Allard’s life, her mother, Francisca Allard, noticed something wasn’t quite right with her beautiful daughter. Raegen would seem upset after she ate and...
7-May-2018 4:20 PM EDT Add to Favorites
With the unexpected discovery of a panel of peptides from several proteins encoded by the parasite that causes malaria, new research underway at Seattle Children’s Research Institute could pave the way for a rapid screening test capable of...
4-May-2018 11:05 AM EDT Add to Favorites
Despite its substantial impact on pregnancy outcomes, scientists know little about how group B streptococcus (GBS) establishes an in utero infection. In a paper published in the Journal of Clinical Investigation, Dr. Lakshmi Rajagopal, a principal...
11-Apr-2018 12:05 PM EDT Add to Favorites
A decade ago, the late Seattle Children’s surgeon, Dr. Richard Grady, began traveling to India to provide urgent surgical care to children with a complex disorder called bladder exstrophy. An article in JAMA Surgery documents Grady's work through...
19-Mar-2018 2:30 PM EDT Add to Favorites
Seattle Children’s today announced it has received the second largest single charitable gift in its 111-year history as the residual beneficiary of the estate of Bruce Leven. The landmark bequest is expected to exceed $60 million.
13-Feb-2018 10:00 AM EST Add to Favorites
Eight years ago, Dr. Jeff Avansino, a surgeon at Seattle Children’s, and his wife, Dr. Amy Criniti, welcomed their third child – a boy named Luke.
9-Feb-2018 10:05 AM EST Add to Favorites
Advances in engineering T cells to treat cancer are paving the way for new immunotherapies targeted at autoimmune diseases, including type 1 diabetes. Now, researchers are also investigating therapies that reprogram T cells to “turn down” an...
13-Dec-2017 12:05 PM EST Add to Favorites
Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplant
Results from a phase 2 clinical trial, presented by Seattle Children’s Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute...
7-Dec-2017 2:00 PM EST Add to Favorites
see all news
Pediatric Oncology Expert Available to Discuss Larotrectinib Data Published in New England Journal of Medicine
16-Feb-2018 10:00 AM EST
Experts at Seattle Children's Hospital have put together a Healthy Child Checklist to ensure that children "“ and parents "“ are prepared for the first day of school.
24-Jul-2009 1:00 PM EDT